Adverse effects of antibiotics in children with cancer: are short-course antibiotics for febrile neutropenia part of the solution?

被引:4
作者
Butters, Coen [1 ,2 ,3 ]
Thursky, Karin [4 ,5 ,6 ]
Hanna, Diane T. [7 ]
Cole, Theresa [2 ,3 ,8 ]
Davidson, Andrew [3 ,9 ,10 ,11 ,12 ]
Buttery, Jim [3 ,11 ,13 ,14 ]
Haeusler, Gabrielle [2 ,3 ,4 ,5 ,11 ]
机构
[1] John Hunter Childrens Hosp, Dept Gen Paediat & Adolescent Med, Newcastle, Australia
[2] Murdoch Childrens Res Inst, Infect & Immun, Parkville, Australia
[3] Univ Melbourne, Dept Paediat, Parkville, Australia
[4] Peter MacCallum Canc Ctr, Dept Infect Dis, Parkville, Australia
[5] Univ Melbourne, Natl Ctr Antimicrobial Stewardship, Dept Infect Dis, Parkville, Australia
[6] Univ Melbourne, Dept Med, Parkville, Australia
[7] Royal Childrens Hosp, Childrens Canc Ctr, Parkville, Australia
[8] Royal Childrens Hosp, Allergy & Immunol, Parkville, Australia
[9] Royal Childrens Hosp, Dept Anaesthesia, Parkville, Australia
[10] Univ Melbourne, SAEFVIC, Parkville, Australia
[11] Royal Childrens Hosp, Infect Dis Unit, Parkville, Australia
[12] Murdoch Childrens Res Inst, Melbourne Childrens Trials Ctr, Parkville, Australia
[13] Melbourne Childrens Campus, Ctr Hlth Analyt, Parkville, Australia
[14] Murdoch Childrens Res Inst, Hlth Informat Grp, Parkville, Australia
关键词
pediatric; febrile neutropenia; microbiome; hematopoietic stem cell transplant; acute leukemia; antimicrobial resistance; graft-versus-host disease; CLOSTRIDIUM-DIFFICILE INFECTION; STEM-CELL TRANSPLANTATION; VERSUS-HOST-DISEASE; PEDIATRIC ONCOLOGY PATIENTS; RISK-FACTORS; INTESTINAL MICROBIOTA; ANTIMICROBIAL THERAPY; CLINICAL-OUTCOMES; BACTEREMIA; RECIPIENTS;
D O I
10.1080/14787210.2023.2171987
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
IntroductionFebrile neutropenia is a common complication experienced by children with cancer or those undergoing hematopoietic stem cell transplantation. Repeated episodes of febrile neutropenia result in cumulative exposure to broad-spectrum antibiotics with potential for a range of serious adverse effects. Short-course antibiotics, even in patients with high-risk febrile neutropenia, may offer a solution.Areas coveredThis review addresses the known broad effects of antibiotics, highlights developments in understanding the relationship between cancer, antibiotics, and the gut microbiome, and discusses emerging evidence regarding long-term adverse antibiotic effects. The authors consider available evidence to guide the duration of empiric antibiotics in pediatric febrile neutropenia and directions for future research.Expert opinionBroad-spectrum antibiotics are associated with antimicrobial resistance, Clostridioides difficile infection, invasive candidiasis, significant disturbance of the gut microbiome and may seriously impact outcomes in children with cancer or undergoing allogenic hematopoietic stem cell transplant. Short-course empiric antibiotics are likely safe in most children with febrile neutropenia and present a valuable opportunity to reduce the risks of antibiotic exposure.
引用
收藏
页码:267 / 279
页数:13
相关论文
共 132 条
[31]   Epidemiology and Clinical Outcomes of Multidrug-resistant, Gram-negative Bloodstream Infections in a European Tertiary Pediatric Hospital During a 12-month Period [J].
Folgori, Laura ;
Livadiotti, Susanna ;
Carletti, Michaela ;
Bielicki, Julia ;
Pontrelli, Giuseppe ;
Degli Atti, Marta Luisa Ciofi ;
Bertaina, Chiara ;
Lucignano, Barbara ;
Ranno, Stefania ;
Carretto, Edoardo ;
Muraca, Maurizio ;
Sharland, Mike ;
Bernaschi, Paola .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2014, 33 (09) :929-932
[32]  
Freifeld AG, 2011, CLIN INFECT DIS, V52, pE56, DOI 10.1093/cid/cir073
[33]   Decontamination therapy in allo-HCT [J].
Galazka, Przemysaw ;
Styczynski, Jan ;
Czyewski, Krzysztof ;
Salamonowicz-Bodzioch, Magorzata ;
Fraczkiewicz, Jowita ;
Zajac-Spychala, Olga ;
Zaucha-Prazmo, Agnieszka ;
Gozdzik, Jolanta ;
Bilinski, Jaroslaw ;
Basak, W. Grzegorz .
CURRENT RESEARCH IN TRANSLATIONAL MEDICINE, 2021, 69 (03)
[34]   The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia [J].
Galloway-Pena, Jessica R. ;
Smith, Daniel P. ;
Sahasrabhojane, Pranoti ;
Ajami, Nadim J. ;
Wadsworth, W. Duncan ;
Daver, Naval G. ;
Chemaly, Roy F. ;
Marsh, Lisa ;
Ghantoji, Shashank S. ;
Pemmaraju, Naveen ;
Garcia-Manero, Guillermo ;
Rezvani, Katayoun ;
Alousi, Amin M. ;
Wargo, Jennifer A. ;
Shpall, Elizabeth J. ;
Futreal, Phillip A. ;
Guindani, Michele ;
Petrosino, Joseph F. ;
Kontoyiannis, Dimitrios P. ;
Shelburne, Samuel A. .
CANCER, 2016, 122 (14) :2186-2196
[35]   Safety and Efficacy of Prophylactic Levofloxacin in Pediatric and Adult Hematopoietic Stem Cell Transplantation Patients [J].
Gardner, Julia C. ;
Courter, Joshua D. ;
Dandoy, Christopher E. ;
Davies, Stella M. ;
Teusink-Cross, Ashley .
TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (03) :167.e1-167.e5
[36]   Cancer and the microbiota [J].
Garrett, Wendy S. .
SCIENCE, 2015, 348 (6230) :80-86
[37]   The Impact of Antibiotic-Mediated Modification of the Intestinal Microbiome on Outcomes of Allogeneic Hematopoietic Cell Transplantation: Systematic Review and Meta-Analysis [J].
Gavriilaki, Maria ;
Sakellari, Ioanna ;
Anagnostopoulos, Achilles ;
Gavriilaki, Eleni .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (09) :1738-1746
[38]  
Goloshchapov O., 2021, CELL THER TRANSPLANT, V10, P69, DOI DOI 10.18620/CTT-1866-8836-2021-10-1-69-78
[39]   Enteral metronidazole for the prevention of graft versus host disease in pediatric marrow transplant recipients: results of a pilot study [J].
Guthery, SL ;
Heubi, JE ;
Filipovich, A .
BONE MARROW TRANSPLANTATION, 2004, 33 (12) :1235-1239
[40]   Clostridioides difficile infection in paediatric patients with cancer and haematopoietic stem cell transplant recipients [J].
Haeusler, Gabrielle M. ;
Lehrnbecher, Thomas ;
Agyeman, Phillip K. A. ;
Loves, Robyn ;
Castagnola, Elio ;
Groll, Andreas H. ;
van de Wetering, Marianne ;
Aftandilian, Catherine C. ;
Phillips, Bob ;
Chirra, Krishna M. ;
Schneider, Christine ;
Dupuis, Lee L. ;
Sung, Lillian .
EUROPEAN JOURNAL OF CANCER, 2022, 171 :1-9